Thursday, September 25, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Amazon’s Cloud Ambitions Spark Analyst Optimism for Stock Revival

Robert Sasse by Robert Sasse
September 25, 2025
in Analysis, E-Commerce, Nasdaq, Tech & Software, Turnaround
0
Amazon Stock
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

After a period of notable underperformance that saw it lag behind its “Magnificent Seven” peers, Amazon is attracting renewed attention from Wall Street. A significant vote of confidence from Wells Fargo suggests a potential turnaround may be brewing, centered on the company’s cloud computing division, AWS.

Analyst Upgrade Points to Accelerated Cloud Growth

In a decisive move on Wednesday, Wells Fargo analyst Ken Gawrelski raised his rating on Amazon shares from “Equal Weight” to “Overweight.” The upgrade stems from what the analyst described as “greater conviction” in an impending acceleration of growth at Amazon Web Services. The bank’s revised forecast is notably bullish, projecting AWS revenue growth of 22.1% for 2026. This figure substantially outpaces Wells Fargo’s prior estimate of 19.3% and sits well above the Wall Street consensus of 18.8%.

A key catalyst for this optimism is identified as “Project Rainier,” a dedicated AWS data center in Indiana being developed for AI partner Anthropic. Wells Fargo believes these substantial investments in artificial intelligence infrastructure are poised to begin yielding significant returns.

Should investors sell immediately? Or is it worth buying Amazon?

Strategic Moves Strengthen Market Position

Further bolstering Amazon’s prospects is a recently announced expanded partnership with German software leader SAP. SAP’s Sovereign Cloud functionalities will be integrated into the new AWS European Sovereign Cloud, a strategic initiative aimed at capturing business from highly regulated industries and public sector clients across Europe. This alliance is expected to considerably enhance Amazon’s competitive standing by addressing complex compliance requirements that many rivals cannot meet.

According to the Wells Fargo analysis, AWS is anticipated to absorb the bulk of its market share losses by 2025. The subsequent years, 2026 and 2027, are forecast to be periods of robust growth, driven by the combination of new data center capacity and strategic AI partnerships—precisely the catalyst needed after Amazon’s recent stock market slump.

The overarching sentiment among market experts remains positive, with 47 out of 50 analysts maintaining either a “Buy” or “Strong Buy” recommendation on the shares. The critical test will be whether Amazon’s quarterly results, due at the end of October, can live up to these heightened expectations.

Ad

Amazon Stock: Buy or Sell?! New Amazon Analysis from September 25 delivers the answer:

The latest Amazon figures speak for themselves: Urgent action needed for Amazon investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 25.

Amazon: Buy or sell? Read more here...

Tags: Amazon
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Take-Two Stock
Analysis

Take-Two Shares Face Pressure Ahead of Earnings Report

September 25, 2025
ImmunityBio Stock
Analysis

ImmunityBio’s Clinical Breakthroughs Fuel Investor Optimism

September 25, 2025
Baidu Stock
AI & Quantum Computing

Baidu’s Dual Engine: AI and Autonomous Driving Fuel Growth Trajectory

September 25, 2025
Next Post
MP Materials Stock

MP Materials Shares Defy Major Deals with Sharp Decline

Synopsys Stock

Can Synopsys Stock Rebound on New TSMC Alliance?

Rocket Lab USA Stock

Rocket Lab Shares Tumble Amid Broader Market Sell-Off

Recommended

Adobe Stock

Adobe’s AI Ambitions Face Investor Scrutiny as Shares Slide

3 weeks ago
Neurotech

Analyst Provides Neutral Rating and Increased Price Target for Everbridge

2 years ago
OHI stock news

Analyst Ben Haynor Recommends Buying Shares of Profound Medical with Revised Price Target

2 years ago
Finance_ People trading stocks

Interpreting Unusual Options Activity in the Financial Market

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

ImmunityBio’s Clinical Breakthroughs Fuel Investor Optimism

Baidu’s Dual Engine: AI and Autonomous Driving Fuel Growth Trajectory

Vertiv Shares Face Pressure as Microsoft’s Cooling Tech Sparks Investor Concerns

Texas Instruments: A Tale of Strong Dividends and Market Uncertainty

BigBear.ai Shares Surge on Major US Navy AI Partnership

Snowflake’s Leadership and Strategy Shift: A Tale of Two Narratives

Trending

Eli Lilly Stock
Earnings

Eli Lilly Bets Billions on Unapproved Weight-Loss Pill with Major Texas Facility

by Robert Sasse
September 25, 2025
0

Eli Lilly is making an unprecedented $6.5 billion wager on a single facility in Texas, dedicated to...

Take-Two Stock

Take-Two Shares Face Pressure Ahead of Earnings Report

September 25, 2025
Airbus Stock

Airbus Helicopter Division Secures Major Contracts Amid Industry Challenges

September 25, 2025
ImmunityBio Stock

ImmunityBio’s Clinical Breakthroughs Fuel Investor Optimism

September 25, 2025
Baidu Stock

Baidu’s Dual Engine: AI and Autonomous Driving Fuel Growth Trajectory

September 25, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Eli Lilly Bets Billions on Unapproved Weight-Loss Pill with Major Texas Facility
  • Take-Two Shares Face Pressure Ahead of Earnings Report
  • Airbus Helicopter Division Secures Major Contracts Amid Industry Challenges

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com